Clinical trial: NCT04801459
Section: Alternatives
Subsections: What Are The Advantages To Patients For Participation In This Study?

This clinical trial can evaluate a reliable method for patients in favor of improving the effects of early recovery postoperatively (exhaust, defecation, eating, residual stomach peristalsis, length of hospital stay, etc.) and later gastrointestinal effects (bile reflux, residual gastritis, gastric emptying function), which may make an important contribution to reduce medical costs and potential improvements of the prognosis.
Clinical trial: NCT04801459
Section: Confidentiality
Subsections: What Is The Confidentiality For Patients In This Clinical Trial?

We guarantee that there will never be any personal identification of your information in the research results, even if the research manuscript will be published in a journal. The research materials and specimens will be stored in the research hospital with the special person responsible for the custody. However, the bidding unit, the state food and drug administration and the ethics committee have the right to consult the subject's information. If you agree with the specimens applied to other medical trials by researches involved directly in the studies, we will promise that your personal identification information can not be contained in any datum or document.
Clinical trial: NCT04801459
Section: Participant Responsibilities
Subsections: What Are The Prerequisites For Patient'S Participating In This Study?

Firstly, you must sign this informed consent, representing you are volunteered to participate in this study. Furthermore, you must meet the recruited criteria of this study. They are as follows: no pregnancy, no history of other malignancies, no history of gastric cancer surgery or the neoadjuvant therapy.
Clinical trial: NCT04801459
Section: Possible Risks, Discomforts, and Inconveniences
Subsections: Is There Any Risk To Participate In This Study For Patients?

This study is a non - intervention for gastric cancer clinical trial that does neither interfere with your diagnosis and treatment for gastric cancer nor damage your social relationship.
Clinical trial: NCT04801459
Section: Procedures
Subsections: Research Process

The study mainly collected specimens from two groups of people, including patients with gastric cancer confirmed by the histopathological examination and with potentially curative gastrectomy by the preoperative assessment. After patients sign the informed consents, research doctor will randomly allot group.
Clinical trial: NCT04801459
Section: Purpose of Research
Subsections: What Is The Aim Of Clinical Trial?

The aim of this clinical trial is to evaluate the impact of the different peristaltic direction of gastrointestinal anastomosis in Roux-en-Y reconstruction after distal curative gastrectomy for gastric cancer on effects of early recovery postoperatively (exhaust, defecation, eating, delayed gastric emptying, length of hospital stay, etc.), postoperative complications (wound infection, leakage, intestinal obstruction, re-operation, and readmission occurring within 30 days of surgery), and later gastrointestinal effects (bile reflux, residual gastritis, later gastric emptying function). The research programme and the informed consent have been approved by the ethics committee of the Tianjin cancer Institute and Hospital.